EUVIMEDEUVIMED entdecken
Leserbrief

A case of thrombotic microangiopathy during tislelizumab therapy for lung cancer

Nannan Zhang, Yumeng Zou

Medicina Clínica · 2026-08 · 166 (8) · 107473

DOI: 10.1016/j.medcli.2026.107473 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Medicina Clínica, 2026-08. Verfasst von Nannan Zhang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatrics, The Affiliated Hospital of Qingdao University, Qingdao, China. Electronic address: zqzyzzh@163.com. Die Arbeit nennt 5 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Geriatrics, The Affiliated Hospital of Qingdao University, Qingdao, China. Electronic address: zqzyzzh@163.com.
  • Department of Hematology, The Affiliated Hospital of Qingdao University, Qingdao, China. Electronic address: Miranda1246@163.com.

Zitieren

APA

Zhang, N., & Zou, Y. (2026). A case of thrombotic microangiopathy during tislelizumab therapy for lung cancer. Medicina Clínica, 166(8), 107473. https://doi.org/10.1016/j.medcli.2026.107473

Vancouver

Zhang N, Zou Y. A case of thrombotic microangiopathy during tislelizumab therapy for lung cancer. Medicina Clínica. 2026;166(8):107473. doi:10.1016/j.medcli.2026.107473

BibTeX
@article{Zhang2026,
  author = {Zhang, Nannan and Zou, Yumeng},
  title = {A case of thrombotic microangiopathy during tislelizumab therapy for lung cancer},
  journal = {Medicina Clínica},
  year = {2026},
  volume = {166},
  number = {8},
  pages = {107473},
  doi = {10.1016/j.medcli.2026.107473}
}
Kostenlos starten →